Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Seaboard Corp
SEB
$4.08B
| $23.6M | 0.02% |
8,048
+713
| +10% | +$2.16M |
|
727
UFP Technologies
UFPT
$2.48B
| $23.6M | 0.02% |
535,673
-28,599
| -5% | -$1.22M |
|
728
Ventas
VTR
$46.3B
| $23.6M | 0.02% |
644,095
-2,087,260
| -76% | -$68.9M |
|
729
Camtek
CAMT
$8.06B
| $23.6M | 0.02% |
1,874,100
-6,400
| -0.3% | -$72.7K |
|
730
Automatic Data Processing
ADP
$110B
| $23.6M | 0.02% |
+158,300
| New | +$22.7M |
|
731
Southern Company
SO
$107B
| $23.5M | 0.02% |
453,666
-7,157,372
| -94% | -$398M |
|
732
Adtran
ADTN
$658M
| $23.5M | 0.02% |
2,150,943
+44,840
| +2% | +$463K |
|
733
Towne Bank
TOWN
$3.5B
| $23.5M | 0.02% |
1,246,483
-70,736
| -5% | -$1.31M |
|
734
Chegg
CHGG
$89.3M
| $23.4M | 0.02% |
+347,600
| New | +$18.6M |
|
735
Henry Schein
HSIC
$10B
| $23.4M | 0.02% |
399,912
+85,300
| +27% | +$4.77M |
|
736
Carriage Services
CSV
$555M
| $23.2M | 0.02% |
1,281,000
+63,600
| +5% | +$1.07M |
|
|
GLDD
737
DELISTED
Great Lakes Dredge & Dock
GLDD
| $23.2M | 0.02% |
2,504,301
-7,700
| -0.3% | -$67.3K |
|
|
AD
738
Array Digital Infrastructure
AD
$3.09B
| $23.2M | 0.02% |
751,162
+38,700
| +5% | +$1.19M |
|
|
DRNA
739
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $23.1M | 0.02% |
910,200
+151,100
| +20% | +$3.26M |
|
740
Kaiser Aluminum
KALU
$2.99B
| $23.1M | 0.02% |
313,800
-66,300
| -17% | -$4.72M |
|
741
First Hawaiian
FHB
$3.39B
| $23M | 0.02% |
1,332,900
+144,800
| +12% | +$2.43M |
|
742
United Parks & Resorts
PRKS
$2.04B
| $23M | 0.02% |
1,550,825
-593,400
| -28% | -$8.74M |
|
743
James River Group Holdings
JRVR
$200M
| $23M | 0.02% |
510,125
-53,500
| -9% | -$1.99M |
|
744
KB Home
KBH
$3.45B
| $22.9M | 0.02% |
747,790
-1,832,400
| -71% | -$50.4M |
|
745
Rexford Industrial Realty
REXR
$8.12B
| $22.9M | 0.02% |
553,600
+293,100
| +113% | +$11.8M |
|
746
Universal Health Services
UHS
$10.1B
| $22.9M | 0.02% |
+246,900
| New | +$24.7M |
|
|
CMBT
747
CMB.TECH NV
CMBT
$4.92B
| $22.8M | 0.02% |
2,802,094
+802,491
| +40% | +$7.98M |
|
748
CGI
GIB
$15.5B
| $22.8M | 0.02% |
362,600
-156,000
| -30% | -$9.72M |
|
749
Willis Towers Watson
WTW
$31B
| $22.8M | 0.02% |
115,920
-93,208
| -45% | -$17.8M |
|
|
VAPO
750
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $22.7M | 0.02% |
+69,263
| New | +$14.6M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.